These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6897751)

  • 21. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease.
    Thaulow E; Dale J; Myhre E
    Am J Cardiol; 1984 May; 53(9):1255-8. PubMed ID: 6538740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
    Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T
    Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivatives.
    Smith EF; Darius H; Ferber H; Schrör K
    Eur J Pharmacol; 1985 Jun; 112(2):161-9. PubMed ID: 3896821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation.
    Butler KD; Maguire ED; Smith JR; Turnbull AA; Wallis RB; White AM
    Thromb Haemost; 1982 Feb; 47(1):46-9. PubMed ID: 6461944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of dazoxiben, an inhibitor of thromboxane synthetase, on cold-induced forearm vasoconstriction and platelet behaviour in different individuals.
    Cowley AJ; Jones EW; Carter AJ; Hanley SP; Heptinstall S
    Br J Clin Pharmacol; 1985 Jan; 19(1):1-8. PubMed ID: 2983748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
    Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
    Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
    FitzGerald GA; Brash AR; Oates JA; Pedersen AK
    J Clin Invest; 1983 Oct; 72(4):1336-43. PubMed ID: 6355181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
    Bertelé V; Falanga A; Tomasiak M; Cerletti C; de Gaetano G
    Thromb Haemost; 1984 Feb; 51(1):125-8. PubMed ID: 6326343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of dazoxiben on cerebrovascular resistance in rabbits].
    Rui YC; Sun DX; Long K
    Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):342-5. PubMed ID: 2624120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
    Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage.
    Imura Y; Terashita Z; Nishikawa K
    Thromb Res; 1990 Jul; 59(1):195-205. PubMed ID: 2119075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V; De Gaetano G
    Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dazoxiben, UK 38,485 and aspirin: duration of effect for preventing thrombotic sudden death in rabbits.
    Lindsay LA; Olson RW; Sakane Y; Ghai R; Smith EF
    Thromb Res; 1986 Jul; 43(2):177-86. PubMed ID: 3090734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of nimodipine on platelet aggregation and thrombosis.
    Ren YJ; Lü AG; Zhang GQ; Jia DH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):158-60. PubMed ID: 10374642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.
    Randall MJ; Parry MJ; Hawkeswood E; Cross PE; Dickinson RP
    Thromb Res; 1981 Jul 1-15; 23(1-2):145-62. PubMed ID: 6795753
    [No Abstract]   [Full Text] [Related]  

  • 40. Dazoxiben examined for platelet inhibitory effect in an artificial circulation.
    Goldman M; Hall C; Hawker RJ; McCollum CN
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):61S-65S. PubMed ID: 6681706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.